Characterization of contraction-mediating prostanoid receptors in human penile erectile tissues. 1989

H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
Department of Clinical Pharmacology, Lund University Hospital, Sweden.

The effects of the thromboxane-receptor antagonist L-636,499 were studied on contractions induced by the thromboxane A2 mimic U44069 and by prostaglandin F2 alpha in isolated preparations of the human corpus cavernosum and corpus spongiosum. The objectives were to characterize prostanoid receptors and, in particular, to elucidate whether more than one receptor was involved in prostanoid-induced contraction of penile erectile tissues. L-636,499 at concentrations 10(-6) M to 3 x 10(-5) M induced a parallel shift to the right of the concentration-response curve to U44069 in both corpus cavernosum and corpus spongiosum suggesting competitive antagonism. Schild plots using U44069 as the agonist and L-636,499 as the antagonist revealed slope indexes near unity in both tissues, and the pA2 values were almost identical. In contrast, L-636,499 concentration-dependently reduced the maximum response to prostaglandin F2 alpha, indicating a non-competitive action. The results suggest that the main contraction-mediating prostanoid receptor in human penile erectile tissues is a thromboxane A2 sensitive receptor. However, the presence of more than one contraction-mediating prostanoid receptor cannot be excluded.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010410 Penile Erection The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions. Tumescence, Penile,Nocturnal Penile Tumescence,Penile Tumescence,Erection, Penile,Penile Tumescence, Nocturnal,Tumescence, Nocturnal Penile
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D011450 Prostaglandin Endoperoxides, Synthetic Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. Prostaglandin Endoperoxide Analogs,Prostaglandin Endoperoxide Analogues,Synthetic Prostaglandin Endoperoxides,Analogues, Prostaglandin Endoperoxide,Endoperoxide Analogues, Prostaglandin,Endoperoxides, Synthetic Prostaglandin
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D003988 Dibenzothiepins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
October 2000, British journal of pharmacology,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
August 2003, British journal of pharmacology,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
December 2015, European journal of pharmacology,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
January 1991, Acta physiologica Scandinavica,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
January 1997, World journal of urology,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
March 1985, Prostaglandins,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
September 1995, British journal of pharmacology,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
May 2002, British journal of pharmacology,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
January 1995, Advances in prostaglandin, thromboxane, and leukotriene research,
H Hedlund, and K E Andersson, and M Fovaeus, and F Holmquist, and T Uski
August 1988, Acta physiologica Scandinavica,
Copied contents to your clipboard!